Between 600,000 and 900,000 Americans suffer from ulcerative colitis (UC), yet many do not respond to existing treatments. Now, two major global studies—published in the New England Journal of Medicine and The Lancet—have revealed two promising new therapies that could change the landscape of UC treatment.
Pair of studies identify promising new treatments for ulcerative colitis (Medical Xpress)
0